Author

S. Sevilla

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Assay:metagenomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. D. Duca· 1 shared A. Saliou· 1 shared B. Auch· 1 shared B. Bernard· 1 shared B. Carter· 1 shared B. S. Moda· 1 shared C. Chen· 1 shared C. Sievers· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. D. Duca

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Variability and Bias in Microbiome Metagenomic Sequencing: an Interlaboratory Study Comparing Experimental Protocols

S. P. Forry, S. L. Servetas, J. G. Kralj, K. Soh, M. Hadjithomas, R. Cano, M. Carlin, M. G. de Amorim, B. Auch, M. G. Bakker, T. F. Bartelli, J. P. Bustamante, I. Cassol, M. Chalita, E. Dias-Neto, , S. A. Jackson

This study evaluates how different laboratory methods affect microbiome metagenomic sequencing results through an interlaboratory comparison of 44 labs analyzing shared reference samples.

bioRxiv · Apr 28, 2023Microbiology

Epigenetic silencing by SMYD3 represses tumor intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck.

N. Nigam, B. Bernard, S. Kim, K. Burkitt, D. Tsai, Y. Robbins, C. Sievers, C. T. Allen, R. L. Bennett, T. T. Tettey, B. Carter, R. Bao, L. Rinaldi, M. W. Lingen, H. Sater, , V. Saloura

This study identifies SMYD3 as an epigenetic regulator that suppresses the intrinsic interferon response in HPV-negative HNSCC, offering a potential strategy to enhance immunotherapy response.

bioRxiv · Nov 4, 2022 · PreprintCancer Biology